Terms ending in 2039
Every in-force patent on Insightec, Ltd.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,103,731 | Overcoming Acoustic Field and Skull Non-Uniformities In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 10,765,892 | Systems and Methods for Optimizing Transcranial Ultrasound Focusing In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 11,123,575 | 3D Conformal Radiation Therapy with Reduced Tissue Stress and Improved Positional Tolerance In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 11,918,420 | Improved Reflection Autofocusing In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 12,697,511 | Systems and Methods for Optimizing Transskull Acoustic Treatment In force · Medium confidence | Insightec, Ltd. | In force | Medium confidence | |
| US 11,872,085 | Focused Ultrasound System with Optimized Monitoring of Cavitation In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 12,076,520 | Control of Exogenous Agent Characteristics in Microbubble-Mediated Ultrasound Procedures In force · High confidence | Insightec Ltd. | In force | High confidence | |
| US 11,806,496 | Adaptive, Closed-Loop Ultrasound Therapy In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 11,857,807 | Simulation-Based Drug Treatment Planning In force · High confidence | Insightec, Ltd. | In force | High confidence | |
| US 11,938,343 | Cavitation-Enhanced Targeted Drug Delivery and Dosing In force · High confidence | Insightec, Ltd. | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.